MARLENE SCHMITZ: Open Payments
NPI 1790937498 · SPRINGFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,361 in 62 payments from 33 companies in 2025. Trend: 2023 $1,194 · 2024 $1,161 · 2025 $1,361
Food & beverage: $1,361
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $246 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| ABBVIE INC. | 5 | $83 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| Merck Sharp & Dohme LLC | 4 | $80 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| Stemline Therapeutics Inc. | 3 | $50 |
| GENZYME CORPORATION | 2 | $41 |
| Eisai Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $37 |
Products named: IMDELLTRA (AMG757), Nubeqa, KEYTRUDA, Orserdu, OJJAARA, JEMPERLI, Lenvima, VERZENIO.
Industry payments across NJ — which companies pay providers there.
